Dan Li Jiayin Liu Xue Zhang Jing Han Hui Jin Long Wang Li Feng Zhisong Fan Jing Zuo Yudong Wang
10.2147/CMAR.S387211
Cancer Manag Res
2022 Nov 15;14:3175-3179.
braf v600e nsclc ros1 rearrangement case report lorlatinib combined with dabrafenib and trametinib
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/36411743/
Case Reports
PMC9675326
36411743
Combined Lorlatinib, Dabrafenib, and Trametinib Treatment for ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer with a Lorlatinib-Induced BRAF V600E Mutation: A Case Report
2022